People with COVID-19 Brain Fog Benefit from Photobiomodulation Therapy

People with COVID-19 Brain Fog Benefit from Photobiomodulation Therapy
Contributors
Subscribe to newsletter

Discover how Photobiomodulation Therapy (PBM) utilizes the power of light to stimulate cellular function and restore cognitive clarity, offering new hope to individuals experiencing post-COVID cognitive challenges.

One of the persisting effects of COVID-19 for some individuals is brain fog. This can greatly impact cognitive abilities, memory, and overall mental clarity. However, the latest research, clinical trials, and expert insights surrounding the use of PBM shed light on the potential benefits and promising results of Photobiomodulation Therapy and its role in addressing cognitive impairments.

Learn more about the study here.

Neuronic devices are not medical devices. Neuronic is not providing any medical advice.

These articles might interest you

Neuronic at the 38th Annual Leigh Steinberg Super Bowl Party

For the second year in a row, Neuronic was proud to be a sponsor of the Leigh Steinberg Super Bowl Party. This year’s event was extra special for us as we debuted the Neuronic LIGHT Helmet for the first time, showcasing its cutting-edge infrared light therapy for brain health and recovery.

Businesswire: Introducing the Neuronic LIGHT: A New Era in tPBM Light Therapy

WENDEN, Germany: Neuronic proudly announces the launch of the Neuronic LIGHT, a transcranial photobiomodulation (tPBM) helmet designed to make the benefits of near-infrared light therapy more accessible.